WELCURE

WELCURE DRUGS & PHARMACEUTICALS

Small Cap BSE: 524661 NSE: WELCURE
₹8.65
0.39 (4.72%)
As on 11 August, 2022 | 08:37

Welcure Drugs & Pharmaceuticals Share Price

Welcure Drugs & Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Welcure Drugs & Pharmaceuticals Share Returns

  • Over 1 Month 21.15%
  • Over 3 Month 51.75%
  • Over 6 Month 11.9%
  • Over 1 Year -14.95%

Welcure Drugs & Pharmaceuticals Key Statistics

Welcure Drugs & Pharmaceuticals Investment Rating

  • Master Rating:
  • Welcure Drugs & Pharms. has an operating revenue of Rs. 0.17 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 22% is great, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 148 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Welcure Drugs & Pharmaceuticals Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Operating Expenses Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Operating Profit Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Depreciation Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0

Welcure Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
8.65
0.39 (4.72%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 7.3
  • 50 Day
  • 7.15
  • 100 Day
  • 7.3
  • 200 Day
  • 7.7
  • 20 Day
  • 7.04
  • 50 Day
  • 7.12
  • 100 Day
  • 7.39
  • 200 Day
  • 7.69

Welcure Drugs & Pharmaceuticals Resistance and Support

PIVOT
₹8.18
Resistance
  • First Resistance
  • 8.36
  • Second Resistance
  • 8.45
  • Third Resistance
  • 8.63
Support
  • First Resistance
  • 8.09
  • Second Resistance
  • 7.91
  • Third Resistance
  • 7.82
  • RSI
  • 72.13
  • MFI
  • 72.97
  • MACD Single Line
  • 0.05
  • MACD
  • 0.27

Welcure Drugs & Pharmaceuticals Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 175,967
  • 11,441,374
  • 65.02
  • Week
  • 193,066
  • 13,192,166
  • 68.33
  • 1 Month
  • 274,077
  • 21,874,051
  • 79.81
  • 6 Month
  • 60,458
  • 4,960,553
  • 82.05

Welcure Drugs & Pharmaceuticals Result Highlights

Welcure Drugs & Pharmaceuticals Synopsis

BSE-Medical-Biomed/Biotech

Welcure Drugs & is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 0.11 Cr. and Equity Capital is Rs. 12.12 Cr. for the Year ended 31/03/2022. Welcure Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/08/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1996PLC227773 and registration number is 227773.
  • Market Cap
  • 12
  • Sales
  • 0
  • Shares in Float
  • 1.16
  • No of funds
  • 1
  • Yield
  • Book Value
  • 108.13
  • U/D Vol ratio
  • 0.7
  • LTDebt / Equity
  • Alpha
  • 0.04
  • Beta
  • 0.39

Welcure Drugs & Pharmaceuticals

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 14.12%
  • 14.12%
  • 14.12%
  • Financial Institutions/ Banks
  • 0.01%
  • 0.01%
  • 0.01%
  • Individual Investors
  • 76.91%
  • 76.04%
  • 76.27%
  • Others
  • 8.96%
  • 9.83%
  • 9.6%

Welcure Drugs & Pharmaceuticals Management

  • Name
  • Designation
  • Mr. Sudhir Chandra
  • Managing Director
  • Mr. Dharam Chand Jain
  • Non Executive Director
  • Mr. Murari Lal Bhateja
  • Independent Director
  • Mr. Gagan Juneja
  • Independent Director
  • Ms. Mitashi Bisaria
  • Non Executive Director

Welcure Drugs & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Welcure Drugs & Pharmaceuticals Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-16
  • Quarterly Results
  • 2022-04-15
  • Audited Results
  • 2022-01-22
  • Quarterly Results
  • 2021-10-25
  • Quarterly Results
  • 2021-07-12
  • Quarterly Results

Welcure Drugs & Pharmaceuticals FAQs

What is Share Price of Welcure Drugs & Pharmaceuticals ?

Welcure Drugs & Pharmaceuticals share price is ₹8 As on 11 August, 2022 | 08:23

What is the Market Cap of Welcure Drugs & Pharmaceuticals ?

The Market Cap of Welcure Drugs & Pharmaceuticals is ₹11.7 Cr As on 11 August, 2022 | 08:23

What is the P/E ratio of Welcure Drugs & Pharmaceuticals ?

The P/E ratio of Welcure Drugs & Pharmaceuticals is -1191.5 As on 11 August, 2022 | 08:23

What is the PB ratio of Welcure Drugs & Pharmaceuticals ?

The PB ratio of Welcure Drugs & Pharmaceuticals is 102.1 As on 11 August, 2022 | 08:23

Q1FY23